Medical devices for cystic fibrosis care may be portable reservoirs of potential pathogens.

As recently reported, there is increasing association between the opportunistic pathogen Stenotrophomonas maltophilia and pulmonary exacerbations in cystic fibrosis (CF) . There has been further literature regarding approaches for surveillance of S. maltophilia in this patient population, potential prediction of clinical outcomes based on such monitoring and, in light of escalating incidence of multidrug resistance , the potential benefit of subsequent early and appropriate antimicrobial treatment 3 .